Join to View Full Profile
National Institutes of Health Clinical Center10 Center Dr Bldg 10 Rm 2C306Bethesda, MD 20892
Phone+1 301-594-9578
Dr. Calvo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2006 - 2008- National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 2003 - 2006
University of California San Diego School of MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2006 - 2026
MD State Medical License 2004 - 2026
American Board of Pathology Pathology - Anatomic- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel.Arsene M Mekinian, Sophie Georgin-Lavaille, Marcela A Ferrada, Sinisa Savic, Matthew J Koster
Arthritis & Rheumatology. 2025-08-11 - Single-cell spatial transcriptomics reveals immunotherapy-driven bone marrow niche remodeling in AML.Gege Gui, Molly A Bingham, Julius R Herzog, Abigail Wong-Rolle, Laura W Dillon
Science Advances. 2025-07-11 - Complete Response in Hairy Cell Leukemia to Anti-CD22 CAR T-Cell Therapy.Robert J Kreitman, Brett Schroeder, Evgeny Arons, Constance Yuan, Hao-Wei Wang
JCO Precision Oncology. 2025-07-01
Abstracts/Posters
- GATA2-Dependent Developmental and Regenerative NetworksKatherine R. Calvo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Long Term Follow-up of a Phase II Study of Cladribine with Concurrent Rituximab in Patients with Hairy Cell Leukemia VariantKatherine R. Calvo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Single-Cell RNA Sequencing Reveals a Distinct Transcriptome Signature of Hematopoiesis in GATA2 DeficiencyKatherine R. Calvo, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- A Phase 2 Study of Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide Maintenance (KRd-r) in Newly Diagnosed Multiple Myeloma (NDMM): Sustained Long Term D...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome(MDS)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
